Special Issue "EVs in Cross-Talk between Cancer and Immune Cells"
Deadline for manuscript submissions: 31 July 2020.
Interests: extracellular vesicles; innate immunity; immunotherapy of cancer; inflammation; tumor immunology
Extracellular vesicles (EVs), their heterogeneity and role in modulation of anticancer immune response or cancer development are a rapidly growing field of research. These highly specific sentinels can transport diverse material (cargo), which may be incorporated both by cells in a local tumor microenvironment and in distant organs and tissues, affecting their functions. As EVs are now being considered a form of communication between cells, it is only fitting to discuss them in the aspect of cellular cross-talk, both in a paracrine and autocrine manner, especially in the context of tumor development. This open-access Special Issue will bring together original research and review articles on these interactions mediated by EVs, with emphasis on cross-talk between cancer and immune cells.
Topics of this Special Issue include but are not limited to:
- Identification and new aspects of interactions of cancer and immune cells mediated by EVs of tumor and nontumor origin;
- Analysis of receptors involved in a cross-talk between cancer and immune cells mediated by EVs;
- Modification of immune cell functions and activation status by tumor-derived EVs, based on their specific cargo;
- Tumor promotion and development supported by EVs of immune-cell origin;
- Techniques for the analysis of specific interactions between cancer and immune cells mediated by EVs.
Prof. Dr. Jarek Baran
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Extracellular vesicles
- Cancer screening and cancer biomarkers
- Cellular communications
- Cancer invasion
- Metastatic niche
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Myeloid cell modulation by tumor-derived EVs
Authors: Viktor Umansky; et al.
Title: Tumor-derived exosomes and their role in cancer progression and immune therapies of cancer
Authors: Theresa L. Whiteside; et al.